DAA	direct-acting antiviral
HCV	hepatitis C virus
LT	liver transplantation
HCC	hepatocellular carcinoma
SVR	sustained virological response
MELD	model of end-stage liver disease
IFN	interferon
AFP	alpha-fetoprotein
SAE	serious adverse event
TNM	tumor-node-metastasis
OR	odds ratio
PT	prothrombin time
TACE	trans-arterial chemoembolization
TIPS	transjugular intrahepatic portosystemic shunt
ALT	alanine aminotransferase
BMI	body mass index
INR	international normalized ratio